Technological innovation is a strategic choice for addressing major health challenges. On January 21st and 22nd, 2024, the Group held a life science sharing session: “The Future of life·Break boundaries with science” in Zhuhai, the Guangdong-Hong Kong-Macao Greater Bay Area. The Group's executives and over 1,000 distributors from all over the world attended the conference, to discuss how to promote people's wellness by technological innovation and witness the launch of the Group's new products.

All participants agreed that health is the most important indicator of a happy life. Health is the one, while everything else is the zeros. Without health, everything means nothing. Enhance innovation in key generic technologies, cutting-edge frontier technologies, and disruptive technologies. Improve capability of indigenous innovation in key generic technologies, to seize cutting-edge hubs of industrial future development. Provide strong support for the building of world wellness and S&T large enterprises, and strengthen the people's fitness.

Achieve breakthroughs in technologies, and accelerate transformation of S&T achievements, to fulfil the zero breakthrough. At the conference, the Group officially launched its new healthcare product, the GBC Life Gene Energy Capsule, based on the "2 major core technologies" and the "12 advanced technologies". The introduction of this product unlocks the "last mile" of the Corporation's scientific research apparatus in the health sector, transitioning from a state of possession to utilization.

All the distributors present have undergone product experience sessions and harbor considerable confidence in their market potentials. Group leaders have also affirmed that, in the face of recurring health challenges, CFI is committed to accelerating technological research and bolstering its strategic scientific and technological prowess. With its institutional strengths, CFI fosters scientific and technological advantages. With research ability, CFI achieves breakthroughs in S&T researches, command core technologies, and introduce pivotal products that safeguard public health and well-being, thereby making a substantial contribution to the building of a community with a shared future for mankind.

Furthermore, global health enterprises are imperative to embrace health science and technological innovation, which cannot be solely dependent on corporate endeavors. It is crucial to bridge the gap between interdisciplinary innovations, fostering a deep integration of industry, academia, and research, along with vertical collaboration, thereby ensuring that achievements in scientific and technological innovations substantially contribute to the betterment of public health.

After the conference, with physical stores as its carrier, the GBC Life Gene Energy Capsule will be launched globally point by point. This initiative is poised to furnish global distributors with a stable customer base and revenue stream, while also offering comprehensive wellness solutions centered on customers’ needs. The company is dedicated to positioning itself as one of the most extensively utilized and expansive providers of scientific and technological health products on a global scale.